is the fda stopping compounded semaglutide compounding news FDA moves to stop compounding GLP-1 drugs versions of weight loss – FDA free to pursue semaglutide

For example, a recent study found that participants were far more likely to lose 10% or more of their body weight on Wegovy while experiencing roughly the same likelihood of the gastrointestinal side effects that are common with GLP-1 drugs

10.1186/s13643-016-0384-4 [DOI] [PMC free article] [PubMed] [Google Scholar] Parry-Strong A., Langdana F., Haeusler S., Weatherall M., Krebs J

Institutional protocols recommend initiation in the operating room or ICU with cardiac telemetry

There has to be if you go off the medication, then what are you going to do

While most are mild and temporary, its crucial to know which symptoms might need medical attention to ensure your treatment stays safe and effective